loadpatents
name:-0.0069999694824219
name:-0.0049648284912109
name:-0.00130295753479
KAMILA; Sukanta Patent Filings

KAMILA; Sukanta

Patent Applications and Registrations

Patent applications and USPTO patent grants for KAMILA; Sukanta.The latest application filed is for "sonodynamic therapy".

Company Profile
1.7.8
  • KAMILA; Sukanta - Newtownabbey Antrim GB
  • Kamila; Sukanta - Coleraine IE
  • Kamila; Sukanta - Dallas TX
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Sonodynamic Therapy
App 20200114003 - CALLAN; John ;   et al.
2020-04-16
Compounds and derivatives of 2H-pyrido (3,2-b)(1, 4) oxazin 3)4H)-ones as raf kinase and LRRK2 inhibitors
Grant 10,093,681 - Biehl , et al. October 9, 2
2018-10-09
Quinoxaline compounds and derivatives
Grant 9,567,305 - Biehl , et al. February 14, 2
2017-02-14
Compounds and Derivatives of 2H-Pyrido (3,2-b)(1, 4) Oxazin 3)4H)-Ones as raf Kinase and LRRK2 Inhibitors
App 20170008907 - Biehl; Edward R. ;   et al.
2017-01-12
Compounds and derivatives of 2H-pyrido (3,2-b)(1, 4) oxazin 3)4H)-ones as raf kinase and LRRK2 inhibitors
Grant 9,493,452 - Biehl , et al. November 15, 2
2016-11-15
Methods of Making and Using Thioxothiazolidine and Rhodanine Derivatives as HIV-1 and JSP-1 Inhibitors
App 20160250194 - Biehl; Edward R. ;   et al.
2016-09-01
Methods of making and using thioxothiazolidine and rhodanine derivatives as HIV-1 and JSP-1 inhibitors
Grant 9,309,208 - Biehl , et al. April 12, 2
2016-04-12
Quinoxaline Compounds and Derivatives
App 20140135494 - Biehl; Edward R. ;   et al.
2014-05-15
Quinoxaline compounds and derivatives
Grant 8,669,363 - Biehl , et al. March 11, 2
2014-03-11
Methods of Making and Using Thioxothiazolidine and Rhodanine Derivatives as HIV-1 and JSP-1 Inhibitors
App 20130253021 - Biehl; Edward R. ;   et al.
2013-09-26
Quinoxaline Compounds and Derivatives
App 20120245352 - Biehl; Edward A. ;   et al.
2012-09-27
Compounds and Derivatives of 2H-Pyrido (3,2-b)(1, 4) Oxazin 3)4H)-Ones as raf Kinase and LRRK2 Inhibitors
App 20120245347 - Biehl; Edward A. ;   et al.
2012-09-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed